Intravenous lidocaine in central pain

Attal, Nadine; Gaudé, V; Brasseur, L.; Dupuy, Marie; Guirimand, Frédéric; Parker, Fabrice; Bouhassira, Didier

doi:10.1212/wnl.54.3.564

Cited by 268 publications

(157 citation statements)

References 40 publications

Supporting

Mentioning

147

Contrasting

Unclassified

Order By: Relevance

“…Lidocaine, an intravenously administered analgesic drug, was shown to be effective in treating post-SCI pain, [51][52][53] with one exception. 55 The one exception may be due to the fact the study's authors used only half the dosage seen in the other studies with a small sample size.…”

Section: Discussionmentioning

confidence: 99%

“…Following the lidocaine injections, 13 patients reported a significant mean reduction in pain from baseline averaging 2 hours when compared to placebo (p<0.01). Attal et al, 52 reported on 15 patients who received lidocaine intravenously and experienced a greater reduction in pain than those who received placebo, with an effect lasting up to 45 minutes post injection, and a reduction in the intensity of brush-induced allodynia and mechanical hyperalgesia. In a RCT study by Finnerup et al, 53 those patients who received lidocaine intravenously (n=24) in two treatment sessions 6 days apart reported significantly less pain than those who did not receive lidocaine.…”

Section: Analgesics For Sci Painmentioning

confidence: 99%

See 1 more Smart Citation

A Systematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury

Teasell

Mehta

Aubut

et al. 2010

Archives of Physical Medicine and Rehabilitation

150

View full text Add to dashboard Cite

Objective-To conduct a systematic review of published research on the pharmacological treatment of pain after spinal cord injury (SCI).Data Sources-Medline, CINAHL, EMBASE and PsycINFO databases were searched for articles published 1980 to June 2009 addressing the treatment of pain post SCI. Randomized controlled trials (RCTs) were assessed for methodological quality using the PEDro assessment scale, while non-RCTs were assessed using the Downs and Black evaluation tool. A level of evidence was assigned to each intervention using a modified Sackett scale.Study Selection-The review included randomized controlled trials and non-randomized controlled trials which included prospective controlled trials, cohort, case series, case-control, prepost and post studies. Case studies were included only when there were no other studies found.Data Extraction-Data extracted included the PEDro or Downs and Black score, the type of study, a brief summary of intervention outcomes, type of pain, type of pain scale and the study findings.. Data Synthesis-Articles selected for this particular review evaluated different interventions in the pharmacological management of pain post SCI. 28 studies met inclusion criteria: there were 21 randomized controlled trials of these 19 had Level 1 evidence. Treatments were divided into five Conclusions-Most studies did not specify participants' types of pain; hence making it difficult to identify the type of pain being targeted by the treatment. Anticonvulsant and analgesic drugs had the highest levels of evidence and were the drugs most often studied. Gabapentin and pregabalin had strong evidence (five Level 1 RCTs) for effectiveness in treating post-SCI neuropathic pain, as did intravenous analgesics (lidocaine, ketamine and morphine) but the latter only had short term benefits. Tricyclic antidepressants only showed benefit for neuropathic pain in depressed individuals. Intrathecal baclofen reduced musculoskeletal pain associated with spasticity; however there was conflicting evidence for the reduction in neuropathic pain. Studies assessing the effectiveness of opioids were limited and revealed only small benefits. Cannabinoids showed conflicting evidence in improving spasticity related pain. Clonidine and morphine, when given together, had a significant synergistic neuropathic pain-relieving effect.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Analgesics For Sci Painmentioning

confidence: 99%

A Systematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury

Teasell

Mehta

Aubut

et al. 2010

Archives of Physical Medicine and Rehabilitation

150

View full text Add to dashboard Cite

show abstract

“…For both at-level and below-level neuropathic pain, we suggest that first-line treatment is systemic lignocaine, [16][17][18] in the acute, in-patient setting and gabapentin [19][20][21] in the subacute or chronic setting. If gabapentin fails to provide adequate relief, we would suggest the use of a tricyclic antidepressant such as amitriptyline or nortriptyline or a weak opioid such as tramadol as a second-line treatment.…”

Section: At-level and Below-level Neuropathic Painmentioning

confidence: 98%

A proposed algorithm for the management of pain following spinal cord injury

2005

View full text Add to dashboard Cite

Study design: Review. Objectives: To review published articles on the assessment, diagnosis and treatment of pain following spinal cord injury (SCI) and to synthesise evidence from these materials to formulate and propose a systematic approach to management. Methods: Relevant articles regarding the treatment of pain were identified from electronic databases using the search terms (('spinal cord injury' or 'spinal cord injuries') and 'pain') and both ('treatment') and ('randomised controlled trials'). Relevant articles were also identified through citations in indexed journal publications and book chapters on this topic. Results: Review of the literature indicates that there are a large variety of treatments used in the management of pain following SCI with a small number supported by strong evidence for effectiveness. A treatment algorithm is proposed based on identification of underlying pain contributors and application of appropriate treatment. Conclusion: Although there are relatively few studies clearly indicating efficacy in this population, an algorithm for the management of pain following SCI might assist to maximise our effectiveness in the treatment of this condition. It is recognised that choice of treatment is also determined by factors such as medication availability, cost and side effects as well as the preferences and characteristics of the person being treated. Nevertheless, an algorithm is proposed as a way to synthesise our current level of knowledge, identify gaps for further study and aid in the management of this difficult problem.

show abstract

“…[62][63][64] One trial also included patients with stroke. 63 Two of the studies found a significant reduction in pain intensity with intravenous lidocaine compared with placebo, 62,63 whereas the third found no significant difference.…”

Section: Intravenous Lidocainementioning

confidence: 99%

The CanPain SCI Clinical Practice Guidelines for Rehabilitation Management of Neuropathic Pain after Spinal Cord: Recommendations for treatment

et al. 2016

View full text Add to dashboard Cite

Study design: Clinical practice guidelines. Objectives: To develop the first Canadian clinical practice guidelines for treatment of neuropathic pain in people with spinal cord injury (SCI). Setting: The guidelines are relevant for inpatient and outpatient SCI rehabilitation settings in Canada. Methods: The CanPainSCI Working Group reviewed the evidence for different treatment options and achieved consensus. The Working Group then developed clinical considerations for each recommendation. Recommendations for research are also included. Results: Twelve recommendations were developed for the management of neuropathic pain after SCI. The recommendations address both pharmacologic and nonpharmacologic treatment modalities. Conclusions: An expert Working Group developed recommendations for the treatment of neuropathic pain after SCI that should be used to inform practice.

show abstract

Intravenous lidocaine in central pain

Abstract: Systemic lidocaine can induce a significant and selective reduction of several components of pain caused by CNS injuries. The observed preferential antihyperalgesic and antiallodynic effects of this drug suggest a selective central action on the mechanisms underlying these evoked pains.

Cited by 268 publications

References 40 publications

A Systematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury

A Systematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury

A proposed algorithm for the management of pain following spinal cord injury

The CanPain SCI Clinical Practice Guidelines for Rehabilitation Management of Neuropathic Pain after Spinal Cord: Recommendations for treatment

Contact Info

Product

Resources

About